World Malaria Report 2024 released by World Health Organization (WHO)

Link copied successfully!

Key Findings

Globally, Malaria cases rose to 263 million in 2023, with an incidence of 60.4 per 1000 population at risk, up from 58.6 in 2022.
The WHO African Region accounted for 94% of global cases.
Findings related to India:
- Decline in Malaria Cases: Reduced by 69%, from 6.4 million in 2017 to 2 million in 2023.
- Decline in Malaria deaths: declined by 68%, from 11,100 in 2017 to 3,500 in 2023.
- In 2024, India officially exited the High Burden to High Impact (HBHI) group.

It is a life-threatening disease caused by Plasmodium parasites, transmitted to humans through the bites of infected female Anopheles mosquitoes.
Geographical prevalence: Mostly found in tropical countries.
Symptoms: Fever, chills and headache, fatigue etc.
Five Plasmodium species cause malaria in humans: P. falciparum, P. vivax, P. malariae, P. ovale, P. knowlesi.
- P. falciparum and P. Vivax pose the greatest threat.
Malaria Vaccines: RTS,S/AS01 vaccine (WHO approved first vaccine in 2021), R21/Matrix-M (WHO approved second vaccine in 2023 ).

WHO Global technical strategy for malaria 2016–2030, updated in 2021, provides a technical framework for all malaria-endemic countries.
National Strategic Plan: Malaria Elimination 2023-27

Biological vulnerability: pertains to physiological characteristics, such as sex characteristics, age, immune response and other genetic factors.
Environmental Factors: For instance climate variability and land-use changes exacerbate exposure.
Social and Economic Factors: Vulnerabilities arise from socioeconomic status, gender inequalities, disability, ethnicity, and migrant status.
Structural Challenges: Conflict, migration, and disruptions in healthcare access increase malaria risk.